Harbor Clinical Shares Insights on Pharmacovigilance Operations in Interview with Flex Databases

[January 19, 2026] - Harbor Clinical, a Boston-based Contract Research Organization (CRO), recently took part in an in-depth interview with Flex Databases, sharing its perspective on pharmacovigilance operations, technology, and long-term collaboration in clinical research.

The interview features Ajay Sadhwani, Senior Vice President of Operations at Harbor Clinical, and focuses on how CROs can deliver flexible, study-based pharmacovigilance services while maintaining regulatory compliance, operational efficiency, and a strong focus on patient safety.

During the discussion, Harbor Clinical addressed key challenges commonly faced in pharmacovigilance, including system flexibility, customer segregation, validation requirements, and the importance of reliable technology to support both small and growing study portfolios.

“Pharmacovigilance is one of the first areas customers ask about, including which system is being used and how safety data is managed,” said Sadhwani during the interview. “Technology plays a critical role in enabling efficient case management, regulatory submissions, and data traceability.”

The conversation also covered Harbor Clinical’s experience working with validated, cloud-based systems, emphasizing the importance of structured implementation, inspection readiness, and responsive support in day-to-day operations. Particular attention was given to the value of technology partnerships that evolve alongside CRO and sponsor needs.

Representing Flex Databases, Marietta, Global Director, led the interview and guided the discussion toward real-world operational considerations rather than theoretical system capabilities. The exchange reflects a shared commitment to practical, scalable solutions that support regulatory expectations and patient safety.

The full interview is available on Flex Databases’ official YouTube channel and forms part of the company’s ongoing initiative to share insights from CROs, sponsors, and industry leaders on the evolving role of technology in clinical research.